Abiopharma

🔍 Klein-Boelting Ralf (Director)

Company: NIQ Global Intelligence plc (NIQ)

Report Date: 2026-08-20

Detailed Transactions and Holdings:

• Sold 1,956 shares of Ordinary Shares at $18.31 per share (Direct)
  Date: 2026-08-20 | Code: F | equity_swap_involved: 0 | shares_owned_after: 35,272.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 10,071 shares of Phantom Stock Units (Derivative)
  Date: 2026-08-20 | Code: H | shares_owned_after: 10,071.00 | Footnotes: F2, F2, F2

Footnotes:

• F1: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of restricted share units ("RSUs") that vested on August 20, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.
• F2: Each phantom stock unit represents the right to receive, on a 1-for-1 basis, the value of one ordinary share, payable in cash or stock upon settlement, at the election of the issuer, and subject to vesting and payment terms under the applicable award agreements.